FDA Recalls Lithium Carbonate ER Tablets Due to Labeling Mixup
Aidapak Services, LLC is recalling Lithium Carbonate ER tablets because they may be mislabeled as Vitamin B Complex Prolonged Release tablets.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that might cause temporary or medically reversible adverse health consequences. The hazard is a labeling mixup, which fits the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Lithium Carbonate ER, Tablet, 300 mg, NDC 00054002125, due to a labeling mixup. The recall involves 2,400 tablets with pedigree AD39564_1 and an expiration date of 5/13/2014.
The FDA has identified that the Lithium Carbonate ER tablets may be potentially mislabeled as Vitamin B Complex Prolonged Release, Tablet, 50 mg, NDC 40985022251. The mislabeled product shares the same expiration date of 5/13/2014 but has a different pedigree (AD39588_10).
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. Consumers and healthcare providers should check their inventory for these specific NDC numbers and pedigree codes. If the product is found, it should be returned to the distributor or disposed of according to local regulations.
The recalled product
- Product
- LITHIUM CARBONATE ER, Tablet, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002125.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 2,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- LITHIUM CARBONATE ER
- Tablet
- 300 mg has the following codes: Pedigree: AD39564_1
- EXP: 5/13/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereCalcium Citrate Tablets Recalled for Potential Lithium Carbonate Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Mislabeled Carbamazepine ER Capsules
FDA (Drugs) · 2014-01-22
- ModerateCarbamazepine ER Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Sevelamer Carbonate Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Vitamin B Complex Tablets Due to Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Vitamin B Complex Capsules Due to Labeling Mixup
FDA (Drugs) · 2014-01-22